0001209191-23-031550.txt : 20230522 0001209191-23-031550.hdr.sgml : 20230522 20230522175111 ACCESSION NUMBER: 0001209191-23-031550 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230518 FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gengos Andrew CENTRAL INDEX KEY: 0001563623 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39503 FILM NUMBER: 23945915 MAIL ADDRESS: STREET 1: 21900 BURBANK BOULEVARD STREET 2: 3RD FLOOR CITY: WOODLAND HILLS STATE: CA ZIP: 91367 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Athira Pharma, Inc. CENTRAL INDEX KEY: 0001620463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 453368487 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: (425) 620-8501 MAIL ADDRESS: STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104 CITY: BOTHELL STATE: WA ZIP: 98011 FORMER COMPANY: FORMER CONFORMED NAME: M3 Biotechnology, Inc. DATE OF NAME CHANGE: 20140924 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-05-18 0 0001620463 Athira Pharma, Inc. ATHA 0001563623 Gengos Andrew C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 0 1 0 0 See Below No securities are beneficially owned 0 D No securities are beneficially owned 0.00 Not applicable 0 D Not applicable Chief Financial Officer and Chief Business Officer /s/ Mark Worthington, Attorney-in-fact for Andrew Gengos 2023-05-22